EGFR Antagonists in Cancer TreatmentCIARDIELLO, Fortunato; TORTORA, Giampaolo.The New England journal of medicine. 2008, Vol 358, Num 11, pp 1160-1174, issn 0028-4793, 15 p.Article

A novel approach in the treatment of cancer : Targeting the epidermal growth factor receptorCIARDIELLO, Fortunato; TORTORA, Giampaolo.Clinical cancer research. 2001, Vol 7, Num 10, pp 2958-2970, issn 1078-0432Article

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agentsCIARDIELLO, Fortunato.Drugs (Basel). 2000, Vol 60, pp 25-32, issn 0012-6667, SUP1Article

Key cancer cell signal transduction pathways as therapeutic targetsBIANCO, Roberto; MELISI, Dauide; CIARDIELLO, Fortunato et al.European journal of cancer (1990). 2006, Vol 42, Num 3, pp 290-294, issn 0959-8049, 5 p.Article

Angiogenesis: A target for cancer therapyTORTORA, Giampaolo; MELISI, Davide; CIARDIELLO, Fortunato et al.Current pharmaceutical design. 2004, Vol 10, Num 1, pp 11-26, issn 1381-6128, 16 p.Article

Antisense strategies targeting protein kinase C: Preclinical and clinical developmentTORTORA, Giampaolo; CIARDIELLO, Fortunato.Seminars in oncology. 2003, Vol 30, Num 4, pp 26-31, issn 0093-7754, 6 p., SUP10Article

Chronic inflammation and oxidative stress in human carcinogenesis : Chronic Oxidative Stress and Inflammation: Role in Human Cancer DevelopmentFEDERICO, Alessandro; MORGILLO, Floriana; TUCCILLO, Concetta et al.International journal of cancer. 2007, Vol 121, Num 11, pp 2381-2386, issn 0020-7136, 6 p.Article

Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling : Anti-cancer-drugsBIANCO, Roberto; DAMIANO, Vincenzo; GELARDI, Teresa et al.Current pharmaceutical design. 2007, Vol 13, Num 33, pp 3358-3367, issn 1381-6128, 10 p.Article

Gefitinib. CommentariesCULY, Christine R; FAULDS, Diana; GIACCONE, Giuseppe et al.Drugs (Basel). 2002, Vol 62, Num 15, pp 2237-2250, issn 0012-6667, 14 p.Article

The use of xenograft models for the selection of cancer treatments with the EGFR as an exampleTROIANI, Teresa; SCHETTINO, Clorinda; MARTINELLI, Erika et al.Critical reviews in oncology/hematology. 2008, Vol 65, Num 3, pp 200-211, issn 1040-8428, 12 p.Article

ALK inhibitors in the treatment of advanced NSCLCGRIDELLI, Cesare; PETERS, Solange; SGAMBATO, Assunta et al.Cancer treatment reviews. 2014, Vol 40, Num 2, pp 300-306, issn 0305-7372, 7 p.Article

Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN) : a case reportSCHETTINO, Clorinda; BARESCHINO, Maria Anna; MONACO, Katia et al.Targeted oncology. 2007, Vol 2, Num 4, pp 253-257, issn 1776-2596, 5 p.Article

Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and AsiaCIARDIELLO, Fortunato; TEJPAR, Sabine; NORMANNO, Nicola et al.Targeted oncology. 2011, Vol 6, Num 3, pp 133-145, issn 1776-2596, 13 p.Article

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderlyGRIDELLI, Cesare; MASSARELLI, Erminia; MAIONE, Paolo et al.Cancer. 2004, Vol 101, Num 8, pp 1733-1744, issn 0008-543X, 12 p.Article

Simultaneous blockade of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenograftsDE LUCA, Antonella; ARRA, Claudio; D'ANTONIO, Antonio et al.Oncogene (Basingstoke). 2000, Vol 19, Num 51, pp 5863-5871, issn 0950-9232Article

Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with GefitinibMORGILLO, Floriana; KIM, Woo-Young; KIM, Edward S et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2795-2803, issn 1078-0432, 9 p.Article

Combined blockade of protein kinase A and Bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesisTORTORA, Giampaolo; CAPUTO, Rosa; DAMIANO, Vincenzo et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2537-2544, issn 1078-0432Article

Improving outcomes in colorectal cancer: Where do we go from here?VAN CUTSEM, Eric; BORRAS, Josep Maria; CASTELLS, Antoni et al.European journal of cancer (1990). 2013, Vol 49, Num 11, pp 2476-2485, issn 0959-8049, 10 p.Article

Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitorsMORGILLO, Floriana; D'AIUTO, Elena; TROIANI, Teresa et al.Lung cancer. 2011, Vol 71, Num 3, pp 283-290, issn 0169-5002, 8 p.Article

Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR InhibitionTROIANI, Teresa; NAPOLITANO, Stefania; VITAGLIANO, Donata et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3775-3786, issn 1078-0432, 12 p.Article

Medical treatment of small cell lung cancer: state of the art and new developmentSGAMBATO, Assunta; CASALUCE, Francesca; MAIONE, Paolo et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 15, pp 2019-2031, issn 1465-6566, 13 p.Article

Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab : A single institution retrospective analysisORDITURA, Michele; DE VITA, Ferdinando; GALIZIA, Gennaro et al.Oncology reports. 2009, Vol 21, Num 4, pp 1023-1028, issn 1021-335X, 6 p.Article

Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human cancer cell linesCIARDIELLO, Fortunato; CAPUTO, Rosa; TROIANI, Teresa et al.International journal of cancer. 2001, Vol 93, Num 2, pp 172-178, issn 0020-7136Article

Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor iressa causes cooperative antitumor and antiangiogenic activityTORTORA, Giampaolo; CAPUTO, Rosa; DAMIANO, Vincenzo et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 4156-4163, issn 1078-0432Article

Cetuximab: In the treatment of metastatic colorectal cancer. CommentariesREYNOLDS, Neil A; WAGSTAFF, Antona J; VAN LAETHEM, Jean-Luc et al.Drugs (Basel). 2004, Vol 64, Num 1, pp 109-121, issn 0012-6667, 13 p.Article